Nomoto H, Kito K, Iesaka H, Handa T, Yanagiya S, Miya A, Kameda H, Cho KY, Takeuchi J, Nagai S, Sakuma I, Nakamura A, Atsumi T.
Preferable Effects Of Pemafibrate On Liver Function And Fibrosis In Subjects With Type 2 Diabetes Complicated With Liver Damage Diabetol Metab Syndr, in press IF= 4.7
Sofue H, Kida T, Hirano A, Omura S, Kadoya M, Nakagomi D, Abe Y, Takizawa N, Nomura A, Kukida Y, Kondo N, Yamano Y, Yanagida T, Endo K, Hirata S, Matsui K, Takeuchi T, Ichinose K, Kato M, Yanai R, Matsuo Y, Shimojima Y, Nishioka R, Okazaki R, Takata T, Ito T, Moriyama M, Takatani A, Miyawaki Y, Ito-Ihara T, Yajima N, Kawaguchi T, Fujioka K, Fujii W, Seno T, Wada M, Kohno M, Kawahito Y.
Optimal Dose of Intravenous Cyclophosphamide during remission induction therapy in ANCA-associated vasculitis: a retrospective cohort study of J-CANVAS.
Modern Rheumatology. in press.
IF: 2.2
Maeda A, Tscuchda .......Fujieda Y.... Kirino Y, Nakasjima H, Matsumoto M.
Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome.
Rheumatology (oxford), in press
IF: 7.046
Sakiyama K, Kono M*, Shimizu A, Atsumi T.
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with spontaneous shrinkage in a patient with Sjogren’s syndrome.
J Rheumatol, in press.
IF=3.9
Immunological Medicine Most Cited Article Award 加藤 将先生
Satoka Shiratori-Aso and Daigo Nakazawa.
The involvement of NETs in ANCA-associated vasculitis.
Frontiers in Immunology. in press.
IF=7.3
Moriya H, Kato M, Hisada R, Ninagawa K, Tada M, Sakiyama K, Yasuda M, Kono M, Fujieda Y, Amengual O, Kikuchi Y, Tsujino I, Sato T, Atsumi T.
The chest CT signs for pulmonary veno-occlusive disease correlate with pulmonary hemodynamics in systemic sclerosis.
Rheumatology (Oxford). in press
IF = 5.5
Sekizaki T, Kameda H, Nakamura A, Kuwabara S, Nomoto H, Cho KY, Ishi Y, Motegi H, Miyoshi H, Atsumi T.
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas Pituitary, in press IF = 3.8
Nomoto H, Takahashi Y, Takano Y, Yokoyama H, Tsuchida K, Nagai S, Miya A, Kameda H, Cho KY, Nakamura A, Atsumi T.
Effect of switching to once-weekly semaglutide on non-alcoholic fatty liver disease: The SWITCH-SEMA 1 subanalysis Pharmaceutics, in press IF = 5.4, 5-Y IF= 6.0
Komatsumoto M, Nakazawa D, Endo T, Nishio S, Kawamura T, Miyoshi-Harashima A, Takenaka S, Shiratori-Aso S, Kurotori M, Matsuoka N, Atsumi T.
Successful initiation of hemodialysis for a hemophilia A patient with factor VIII inhibitor: a case report and literature review.
CEN Case Rep. 2023 Jul 25.
IF: 1.0